Whole Blood Gene Expression Testing for Coronary Artery Disease in Nondiabetic Patients: Major Adverse Cardiovascular Events and Interventions in the PREDICT Trial

The majority of first-time angiography patients are without obstructive coronary artery disease (CAD). A blood gene expression score (GES) for obstructive CAD likelihood was validated in the PREDICT study, but its relation to major adverse cardiovascular events (MACE) and revascularization was not a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenberg, Steven, Elashoff, Michael R., Lieu, Hsiao D., Brown, Bradley O., Kraus, William E., Schwartz, Robert S., Voros, Szilard, Ellis, Stephen G., Waksman, Ron, McPherson, John A., Lansky, Alexandra J., Topol, Eric J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349850/
https://www.ncbi.nlm.nih.gov/pubmed/22396313
http://dx.doi.org/10.1007/s12265-012-9353-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349850/
https://www.ncbi.nlm.nih.gov/pubmed/22396313
http://dx.doi.org/10.1007/s12265-012-9353-z

Ejemplares similares